[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353557-105":59,"doc-detail-353557-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-purinergic-signaling-interfaces-in-breast-cancer-angiogenesis-review","The purinergic signaling interfaces in breast cancer angiogenesis - Review","","Cancer consists of disordered cell proliferation and disrupted tissue architecture. Breast cancer is the most common and lethal cancer in women and shows marked molecular, histological, and pathological heterogeneity. Its tumor microenvironment forms a complex ecosystem where endothelial cells drive angiogenesis through new blood vessel formation. Purinergic signaling regulates endothelial function via purines (ATP, ADP, UTP, UDP, adenosine) acting on purinergic receptors, with concentration controlled by ectonucleotidases. The review highlights how ATP and adenosine signaling promotes tumor progression and suggests therapeutic targets for antitumor therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-purinergic-signaling-interfaces-in-breast-cancer-angiogenesis-review/353557/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-purinergic-signaling-interfaces-in-breast-cancer-angiogenesis-review/353557.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the tumor microenvironment contribute to breast cancer angiogenesis?","Question",{"text":112,"@type":113},"The tumor microenvironment is a complex ecosystem that includes transformed tumor cells and multiple non-tumor cells embedded in an altered extracellular matrix. It contains endothelial cells that drive angiogenesis by enabling new blood vessel formation to supply nutrients and oxygen.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does purinergic signaling play in regulating endothelial cells during angiogenesis?",{"text":117,"@type":113},"Purinergic signaling regulates endothelial cell function through purines such as ATP, ADP, UTP, UDP, and adenosine acting on purinergic receptors. Enzymes called ectonucleotidases modulate the concentrations of these signaling molecules.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are ATP and adenosine considered central to breast cancer angiogenesis?",{"text":121,"@type":113},"The tumor microenvironment shows overexpression of ATP and adenosine, which stimulate endothelial cells through purinergic receptors. This stimulation promotes new vessel formation, particularly by supporting pathways such as the release of VEGF, and may therefore be leveraged for antitumor therapies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353557,1790843949,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Purinergic Signalling (2026) 22:13  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1302-025-10119-1  \nThe purinergic signaling interfaces in breast cancer angiogenesis  \nFernanda Cardoso da Silva1 · Jeferson Stabile2 · Cristina Ribas Fürstenau2 · Thaise Gonçalves Araújo1  \nReceived: 9 July 2025 / Accepted: 12 November 2025 / Published online: 23 January 2026 © The Author(s) 2026  \nAbstract  \nCancer is a group of diseases characterized by disordered cell proliferation and loss of tissue architecture. Breast cancer (BC) is the most common and lethal cancer among women, standing out for its molecular, histological and pathological heterogeneity. The BC tumor microenvironment (TME) is a complex ecosystem comprising transformed cells and a multitude of non-tumor cells, embedded in an altered extracellular matrix. Endothelial cells are present, driving angiogenesis, a relevant hallmark that ensures nutrition and oxygenation through the formation of new blood vessels. During this process, a complex network of molecules is released by tumor and endothelial cells, such as Vascular Endothelial Growth Factor (VEGF), that, in turn, induce cancer progression, diffusion, and metastasis. Purinergic signaling also regulates the functioning of endothelial cells involving the action of purines (ATP, ADP, UTP, UDP and adenosine) as signaling in purinergic receptors, with their concentration modulated by enzymes known as ectonucleotidases. This review aims to explore the contribution of purinergic signaling to BC angiogenesis, highlighting potential therapeutic targets currently under scientific focus. In general, the TME presents overexpression of ATP and adenosine, which stimulate endothelial cells through purinergic receptors. This stimulus promotes the formation of new vessels, mainly via the release of VEGF. Thus, purinergic signaling emerges as a central mechanism in BC angiogenesis, with potential to be explored in the development of antitumor therapies.  \nKeywords Adenosine · ATP · Anti-angiogenic · Tumor angiogenesis · Breast cancer  \nAbbreviations  \nAdo  \nADP  \nATP  \nBC  \nbFGF  \nBRCA1/2  \nCAFs  \nCCL2  \nCD39  \nCD73  \ncircRNA  \nCOX-2  \nAdenosine  \nAdenosine diphosphate  \nAdenosine triphosphate Breast cancer  \nBasic fibroblast growth factor Breast cancer gene 1/2  \nCancer-associated fibroblasts C-C motif chemokine ligand 2  \nEctonucleoside triphosphate diphosphohydrolase 1  \nEcto-5’-nucleotidase Circular RNA Cyclooxygenase-2  \n* Thaise Gonçalves Araújo [tgaraujo@ufu.br](tgaraujo@ufu.br)  \n1 Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlândia, Patos de Minas, MG, Brazil  \n2 Laboratory of Vascular Biochemistry, Center for Natural and Human Sciences, Federal University of ABC, Santo André, SP, Brazil  \nCSF-1  \nECM  \nE-NPPs  \nER  \nERK1/2  \nFAK  \nFGF  \nGLUT1  \nGLUT3  \nHDI  \nHER2  \nHER2E  \nHIF-1α IL-1 IL-1β IL-6 Ki-67 LDHAlncRNAMAPK  \nMEK  \nmiRNA  \nColony-stimulating factor 1  \nExtracellular matrix Ectonucleotide pyrophosphatase/ phosphodiesterases  \nEstrogen receptor  \nExtracellular signal-regulated kinase 1/2 Focal adhesion kinase  \nFibroblast growth factor Glucose transporter 1  \nGlucose transporter 3  \nHuman development index  \nHuman epidermal growth factor receptor 2 HER2-enriched  \nHypoxia-inducible factor 1-alpha Interleukin-1  \nInterleukin-1 beta  \nInterleukin-6  \nAntigen Ki-67  \nLactate dehydrogenase ALong non-coding RNA Mitogen-activated protein kinase  \nMitogen-activated protein kinase kinase MicroRNA  \nMMPs  \nPANX1  \nPARP  \nPD-1  \nPD-L1  \nPDGF  \nPDT  \nPHD2  \nPI3K/AKT  \npiRNA PKM2  \nPR  \nRTK  \nSerRSsNDPK-BTAMTGF-β TME  \nTNBC  \nTNF-α  \nUDP  \nUTP  \nVEGF  \nMatrix metalloproteinases Pannexin 1  \nPoly (ADP-ribose) polymerase Programmed cell death protein 1  \nProgrammed death-ligand 1  \nPlatelet-derived growth factor Photodynamic therapy  \nProlyl hydroxylase domain-containing protein 2  \nPhosphoinositide 3-kinase/Protein kinase B  \nPiwi-interacting RNA Pyruvate kinase M2 Progeste","cbCaipa8SPyV9Ewn","https://ap.wps.com/l/cbCaipa8SPyV9Ewn","pdf",6309607,17,"English","# Abstract\n# Keywords and Abbreviations\n# Introduction","[{\"question\":\"How does the tumor microenvironment contribute to breast cancer angiogenesis?\",\"answer\":\"The tumor microenvironment is a complex ecosystem that includes transformed tumor cells and multiple non-tumor cells embedded in an altered extracellular matrix. It contains endothelial cells that drive angiogenesis by enabling new blood vessel formation to supply nutrients and oxygen.\"},{\"question\":\"What role does purinergic signaling play in regulating endothelial cells during angiogenesis?\",\"answer\":\"Purinergic signaling regulates endothelial cell function through purines such as ATP, ADP, UTP, UDP, and adenosine acting on purinergic receptors. Enzymes called ectonucleotidases modulate the concentrations of these signaling molecules.\"},{\"question\":\"Why are ATP and adenosine considered central to breast cancer angiogenesis?\",\"answer\":\"The tumor microenvironment shows overexpression of ATP and adenosine, which stimulate endothelial cells through purinergic receptors. This stimulation promotes new vessel formation, particularly by supporting pathways such as the release of VEGF, and may therefore be leveraged for antitumor therapies.\"}]","The purinergic signaling interfaces in breast cancer angiogenesis - Review | PDF",1790106037,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11bde566ebb4965914e663f0f2ab1b8d.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0de484a340976291b366883a9cec0098.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5cb18ad8144677567a8651128420766.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f123d3bec12f578596122935441ab5c.webp",980,1301]